Ascitic IL‐10 Concentration Predicts Prognosis of Patients Undergoing Cell‐Free and Concentrated Ascites Reinfusion Therapy-Reference-Cited by-同舟云学术

Ascitic IL‐10 Concentration Predicts Prognosis of Patients Undergoing Cell‐Free and Concentrated Ascites Reinfusion Therapy

Published:2019-08-06 Issue:1 Volume:24 Page:90-95
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Ito Tetsuya¹^ORCID,Hanafusa Norio²,Iwase Satoru¹,Noiri Eisei³,Nangaku Masaomi³,Nakagawa Keiichi¹,Miyagawa Kiyoshi⁴

Affiliation:

1. Department of Palliative MedicineThe University of Tokyo Hospital Tokyo Japan

2. Department of Blood PurificationTokyo Women's Medical University Tokyo Japan

3. Department of Hemodialysis and ApheresisThe University of Tokyo Hospital Tokyo Japan

4. Laboratory of Molecular RadiologyCenter for Disease Biology and Integrative Medicine, The University of Tokyo Tokyo Japan

Publisher

Wiley

Subject

Nephrology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1744-9987.12863

Reference22 articles.

1. Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites

2. Single Center Experience of Cell-Free and Concentrated Ascites Reinfusion Therapy in Malignancy Related Ascites

3. Immunosuppressive cytokines (IL-10, TGF-β) genes expression in human gastric carcinoma tissues

4. Preoperative plasma level of IL‐10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer;Szaflarska A;Anticancer Res,2009

5. Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient‐derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways;Molecular Oncology;2024-09-08

2. Reappraisal of a Renovated Cell-free and Concentrated Ascites Reinfusion Therapy for Malignant Ascites;Anticancer Research;2024-02

3. Reappraisal of a renovated cell-free and concentrated ascites reinfusion therapy (KM-CART) for malignant ascites;2023-09-12

4. Occurrence of fever in cell-free and concentrated ascites reinfusion therapy is not related to the primary disease or nature of ascites;Journal of Artificial Organs;2023-05-13

5. Changes in Coagulation and Fibrinolytic Factors in Patients With Cirrhotic Refractory Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy: A Retrospective Observational Study in Japan;In Vivo;2023